Cargando…
Pneumonitis after Stereotactic Thoracic Radioimmunotherapy with Checkpoint Inhibitors: Exploration of the Dose–Volume–Effect Correlation
SIMPLE SUMMARY: Stereotactic body radiation therapy (SBRT) is widely applied for treatment of early stage lung cancer and pulmonary metastases. Modern immune checkpoint blockade (ICB) is progressively used in cancer treatment. Pneumonitis is a relevant side effect of both thoracic SBRT and ICB. Curr...
Autores principales: | Kraus, Kim Melanie, Bauer, Caroline, Feuerecker, Benedikt, Fischer, Julius Clemens, Borm, Kai Joachim, Bernhardt, Denise, Combs, Stephanie Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221463/ https://www.ncbi.nlm.nih.gov/pubmed/35740613 http://dx.doi.org/10.3390/cancers14122948 |
Ejemplares similares
-
Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition
por: Kraus, Kim Melanie, et al.
Publicado: (2023) -
Potential Morbidity Reduction for Lung Stereotactic Body Radiation Therapy Using Respiratory Gating
por: Kraus, Kim Melanie, et al.
Publicado: (2021) -
Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade
por: Kraus, Kim M., et al.
Publicado: (2021) -
Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
por: Lu, Xiaotong, et al.
Publicado: (2022) -
Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
por: Waltenberger, Maria, et al.
Publicado: (2023)